About Neos-R 500 mcg/ml Injection
Neos-R is an injection made by Renata PLC. It contains Neostigmine Methyl Sulphate at a strength of 500 mcg/ml and comes as a 1 ml ampoule and a 5 ml ampoule, each in packs of 5's.
There are 4 brands of Neostigmine Methyl Sulphate listed in Bangladesh. By unit price, Neos-R is among the cheapest of them.
What is Neos-R 500 mcg/ml Injection?
Neos-R 500 mcg/ml injection is produced by Renata PLC and contains the medicine Neostigmine Methyl Sulphate. It belongs to a group of medicines called anti-cholinesterases. These medicines work by interfering with the breakdown of acetylcholine, a natural chemical in the body, so that its effects last longer. Neos-R is given by a healthcare professional in a hospital or clinical setting. It is used in situations such as recovery after certain types of surgery and in some muscle-related conditions. Because it is an injection, it must only be given by a qualified doctor or nurse who can watch the patient's response.
Uses of Neos-R
Neos-R is used to reverse the effect of certain muscle-relaxing medicines given during surgery. It is also used to prevent and treat abdominal swelling and difficulty passing urine after an operation, once a mechanical blockage has been ruled out. In addition, it can be used for control of myasthenia gravis when oral treatment is not practical. Only a doctor can decide whether this medicine is suitable for a particular patient.
How to use Neos-R
Neos-R is given only by a doctor or trained healthcare staff, usually in a hospital. It can be injected into a vein, into a muscle, or under the skin, and the doctor chooses the route. The dose and course are decided by the doctor based on the patient's condition and response. Do not attempt to use this injection yourself. Ask your doctor or pharmacist if you have any questions about how it will be given.
Side effects of Neos-R
Like other medicines, Neos-R can cause side effects. These include nausea, vomiting, increased saliva, diarrhoea and abdominal cramps, which may be more noticeable at higher doses. Signs of too much medicine can include increased stomach discomfort, chest secretions, sweating, involuntary passing of stool or urine, small pupils, eye movements, slow heartbeat, low blood pressure, restlessness and weakness. Tell the doctor or nurse straight away if any of these occur.
Safety and precautions
Neos-R should be used with caution in people with asthma, slow heartbeat, a recent heart attack, epilepsy, low blood pressure, parkinsonism, peptic ulcer or certain other conditions. It is not suitable for people allergic to the medicine or with peritonitis or a mechanical blockage of the bowel or urinary tract. It is in pregnancy category C, and studies in pregnancy are limited, so it should be used in pregnancy only if clearly needed. It is not known whether it passes into breast milk. Tell your doctor if you are pregnant, breastfeeding, or have any of these conditions before receiving it.
Frequently asked questions
What is the price of Neos-R?
The listed price is ৳ 8.00.
How should Neos-R be taken?
Neos-R is an injection given by a doctor or nurse, usually in a hospital. The doctor decides the dose, the route and the course based on your condition. Do not use it yourself; ask your doctor or pharmacist for guidance.
What is Neos-R used for and what kind of medicine is it?
Neos-R contains Neostigmine Methyl Sulphate, an anti-cholinesterase medicine. It is used to reverse certain muscle-relaxing medicines after surgery, to prevent and treat post-operative abdominal swelling and urinary retention, and in some cases of myasthenia gravis.
How should Neos-R be stored?
Store Neos-R in a cool and dry place, protected from light. Keep it out of reach of children. If you are unsure about storage conditions, ask your pharmacist.
- Strength
- 500 mcg/ml
Price in Bangladesh
৳ 7.84 ৳ 8.00 2% off unit price
Price updated: 1 Jul 2022
Indications
Neostigmine Methyl Sulphate is indicated for-
- Reversal of nondepolarising neuromuscular blockade for surgical anesthetic procedures
- The prevention and treatment of post-operative abdominal distention and urinary retention after mechanical obstruction has been excluded.
... Read more
Neostigmine Methyl Sulphate is indicated for-
- Reversal of nondepolarising neuromuscular blockade for surgical anesthetic procedures
- The prevention and treatment of post-operative abdominal distention and urinary retention after mechanical obstruction has been excluded.
- Treatment of the systemic control of Myasthenia Gravis when oral therapy is impractical.
Pharmacology
Neostigmine is a parasympathomimetic, specifically, a reversible cholinesterase inhibitor. By interfering with the breakdown of acetylcholine, Neostigmine indirectly stimulates both nicotinic and muscarinic receptors. It does cross the blood-brain barrier but only poorly. Neostigmine binds to the anionic site of cholinesterase. The drug blocks the active site of acetylcholinesterase; so the enzyme can no longer break down the acetylcholine molecules before they reach the postsynaptic membrane receptors. This allows for the threshold to be reached so a new impulse can be triggered in the next neuron. In myasthenia gravis there are too few acetylcholine receptors. So with the acetylcholinesterase blocked, acetylcholine can bind to the few receptors and trigger a muscular contraction.
Dosage & Administration
Reversal of the effects of Non-depolarizing Neurormuscular Blocking Agents: The usual dose is 0.5 to 2 mg given by slow intravenous injection over 60 seconds; repeated as required. Total dose should not exceed 5 mg (in exceptional cases). When Neostigmine is administered intravenously, it is recommended that Atropine Sulphate (0.6-1.2 mg) also be given intravenously using separate syringe.
Prevention of post-operative abdominal distention and urinary retention: 0.25 mg intramuscularly or subcutaneously as soon as possible after operation; repeat every 4 6 hours for 2-3 days.
Treatment of post-operative abdominal distention: 0.5 mg intramuscularly or subcutaneously or as required.
Treatment of urinary retention: 0.5 mg intramuscularly or subcutaneously. If urination does not occur within an hour, the patient should be catheterized. After the patient has voided, or the bladder has been emptied, continue the 0.5 mg injection every 3 hours, for at least 5 injections.
Symptomatic control of Myasthenia Gravis: 0.5 mg intramuscularly or subcutaneously. Subsequent dose should be based on the individual patient's response.
Neonates: 50-250 micrograms (0.1 to 0.5 ml) every 4 hours.
Children: 200-500 micrograms (0.4 ml to 1 ml) as recommended.
Interaction
Anti-arrhythmic Procainamide, Quinidine and possibly Propafenone antagonise effect of Neostigmine. Antibacterials, Aminoglycosides, Clindamycin, Lincomycin and Polymyxins antagonise effect of Neostigmine.
Contraindications
Neostigmine is contraindicated in patients with known hypersensitivity to the drug. It is also contraindicated in patients with peritonitis or mechanical obstruction of the intestinal or urinary tract.
Side Effects
Nausea, vomiting, increased salivation, diarrhoea and abdominal cramps (more marked with high doses). Signs of overdose are increased gastrointestinal discomfort, bronchial secretions and sweating, involuntary defecation and micturition, miosis, nystagmus, bradycardia, hypotension, agitation, excessive dreaming and weakness eventually leading to fasciculation and paralysis.
Pregnancy & Lactation
Pregnancy Category C. There are no adequate or well-controlled studies of Neostigmine in either laboratory animals or in pregnantwomen. It is not known whether Neostigmine can cause fetal harm when administered to a pregnant woman or can affect reproductive capacity. Neostigmine should be given to a pregnant woman only if clearly needed.
Nonteratogenic Effects: Anticholinesterase drugs may cause uterine irritability and induce premature labor when given intravenously to pregnant women near term.
Nursing Mothers: It is not known whether Neostigmine is excreted in human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions from Neostigmine in nursing infants, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.
Precautions & Warnings
Asthma, bradycardia, recent myocardial infarction, epilepsy, hypotension, parkinsonism, vagotonia, peptic ulceration. Atropine or other antidote to muscarinic effccts may be necessary (particularly when Neostigmine is given by injection), but it should not be given routinely as it may mask signs of overdose.
Storage Conditions
Store in a cool and dry place, protected from light.
Alternative brands of Neostigmine Methyl Sulphate
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.